Amelioration of cardiac hemolytic anemia by sulfinpyrazone therapy.
D000368:Aged; D000743:Anemia, Hemolytic / Q000209:etiology / Q000517:prevention & control*; D000925:Anticoagulants / Q000627:therapeutic use; D005260:Female; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D006801:Humans; D002546:Ischemic Attack, Transient / Q000209:etiology / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D013442:Sulfinpyrazone / Q000627:therapeutic use*
D000925:Anticoagulants; D013442:Sulfinpyrazone